Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cosmo Research Institute serves as the primary research and development hub for the Cosmo Energy Group, specializing in energy, environmental technologies, and life sciences. The institute is globally recognized for its pioneering work on 5-aminolevulinic acid (5-ALA), a naturally occurring amino acid often referred to as a "precursor to life." Through advanced fermentation and chemical synthesis technologies, the institute has developed 5-ALA for diverse applications, including photodynamic diagnosis (PDD) for cancer and metabolic health supplements. Their research supports the commercialization of diagnostic agents and nutraceuticals that leverage the unique metabolic properties of 5-ALA. Based in Saitama, Japan, the institute continues to collaborate with pharmaceutical and academic partners to expand the therapeutic potential of its biological discoveries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cosmo Research Institute.